Detailed Information on Publication Record

AMBROSIONI, Juan, Marta HERNANDEZ-MENESES, Emanuele DURANTE-MANGONI, Pierre TATTEVIN, Lars OLAISON, Tomáš FREIBERGER, John HURLEY, Margaret M HANNAN, Vivian CHU, Bruno HOEN, Asuncion MORENO, Guillermo CUERVO, Jaume LLOPIS and Jose M MIRO. Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000-2012). INFECTIOUS DISEASES AND THERAPY. London: SPRINGER LONDON LTD, 2023, vol. 12, No 4, p. 1083-1101. ISSN 2193-8229. Available from: https://dx.doi.org/10.1007/s40121-023-00763-8.

Other formats: BibTeX LaTeX RIS

TY  - JOUR
ID  - 2379798
AU  - Ambrosioni, Juan - Hernandez-Meneses, Marta - Durante-Mangoni, Emanuele - Tattevin, Pierre - Olaison, Lars - Freiberger, Tomáš - Hurley, John - Hannan, Margaret M - Chu, Vivian - Hoen, Bruno - Moreno, Asuncion - Cuervo, Guillermo - Llopis, Jaume - Miro, Jose M
PY  - 2023
TI  - Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000-2012)
JF  - INFECTIOUS DISEASES AND THERAPY
VL  - 12
IS  - 4
SP  - 1083-1101
EP  - 1083-1101
PB  - SPRINGER LONDON LTD
SN  - 21938229
KW  - Infective endocarditis
KW  - Europe
KW  - Epidemiology
KW  - Cardiac surgery
KW  - Mortality
UR  - https://link.springer.com/article/10.1007/s40121-023-00763-8
N2  - Introduction Infective endocarditis (IE) has undergone important changes in its epidemiology worldwide.Methods The study aimed to compare IE epidemiological features and outcomes according to predefined European regions and between two different time periods in the twenty-first century.Results IE cases from 13 European countries were included. Two periods were considered: 2000-2006 and 2008-2012. Two European regions were considered, according to the United Nations geoscheme for Europe: Southern (SE) and Northern-Central Europe (NCE). Comparisons were performed between regions and periods. A total of 4195 episodes of IE were included, 2113 from SE and 2082 from NCE; 2787 cases were included between 2000 and 2006 and 1408 between 2008 and 2012. Median (IQR) age was 63.7 (49-74) years and 69.4% were males. Native valve IE (NVE), prosthetic valve IE (PVE), and device-related IE were diagnosed in 68.3%, 23.9%, and 7.8% of cases, respectively; 52% underwent surgery and 19.3% died during hospitalization. NVE was more prevalent in NCE, whereas device-related IE was more frequent in SE. Higher age, acute presentation, hemodialysis, cancer, and diabetes mellitus all were more prevalent in the second period. NVE decreased and PVE and device-related IE both increased in the second period. Surgical treatment also increased from 48.7% to 58.4% (p < 0.01). In-hospital and 6-month mortality rates were comparable between regions and significantly decreased in the second period.Conclusions Despite an increased complexity of IE cases, prognosis improved in recent years with a significant decrease in 6-month mortality. Outcome did not differ according to the European region (SE versus NCE).
ER  -

Basic information
Original name	Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000-2012)
Authors	AMBROSIONI, Juan, Marta HERNANDEZ-MENESES, Emanuele DURANTE-MANGONI, Pierre TATTEVIN, Lars OLAISON, Tomáš FREIBERGER (203 Czech Republic, belonging to the institution), John HURLEY, Margaret M HANNAN, Vivian CHU, Bruno HOEN, Asuncion MORENO, Guillermo CUERVO, Jaume LLOPIS and Jose M MIRO.
Edition	INFECTIOUS DISEASES AND THERAPY, London, SPRINGER LONDON LTD, 2023, 2193-8229.

Other information
Original language	English
Type of outcome	Article in a journal
Field of Study	30201 Cardiac and Cardiovascular systems
Country of publisher	United States of America
Confidentiality degree	is not subject to a state or trade secret
WWW	URL
Impact factor	Impact factor: 5.400 in 2022
RIV identification code	RIV/00216224:14110/23:00133680
Organization unit	Faculty of Medicine
Doi	http://dx.doi.org/10.1007/s40121-023-00763-8
UT WoS	000954366500001
Keywords in English	Infective endocarditis; Europe; Epidemiology; Cardiac surgery; Mortality
Tags	14110114, rivok
Tags	International impact, Reviewed
Changed by	Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 29/2/2024 08:10.

Abstract
Introduction Infective endocarditis (IE) has undergone important changes in its epidemiology worldwide.Methods The study aimed to compare IE epidemiological features and outcomes according to predefined European regions and between two different time periods in the twenty-first century.Results IE cases from 13 European countries were included. Two periods were considered: 2000-2006 and 2008-2012. Two European regions were considered, according to the United Nations geoscheme for Europe: Southern (SE) and Northern-Central Europe (NCE). Comparisons were performed between regions and periods. A total of 4195 episodes of IE were included, 2113 from SE and 2082 from NCE; 2787 cases were included between 2000 and 2006 and 1408 between 2008 and 2012. Median (IQR) age was 63.7 (49-74) years and 69.4% were males. Native valve IE (NVE), prosthetic valve IE (PVE), and device-related IE were diagnosed in 68.3%, 23.9%, and 7.8% of cases, respectively; 52% underwent surgery and 19.3% died during hospitalization. NVE was more prevalent in NCE, whereas device-related IE was more frequent in SE. Higher age, acute presentation, hemodialysis, cancer, and diabetes mellitus all were more prevalent in the second period. NVE decreased and PVE and device-related IE both increased in the second period. Surgical treatment also increased from 48.7% to 58.4% (p < 0.01). In-hospital and 6-month mortality rates were comparable between regions and significantly decreased in the second period.Conclusions Despite an increased complexity of IE cases, prognosis improved in recent years with a significant decrease in 6-month mortality. Outcome did not differ according to the European region (SE versus NCE).

Abstract

Introduction Infective endocarditis (IE) has undergone important changes in its epidemiology worldwide.Methods The study aimed to compare IE epidemiological features and outcomes according to predefined European regions and between two different time periods in the twenty-first century.Results IE cases from 13 European countries were included. Two periods were considered: 2000-2006 and 2008-2012. Two European regions were considered, according to the United Nations geoscheme for Europe: Southern (SE) and Northern-Central Europe (NCE). Comparisons were performed between regions and periods. A total of 4195 episodes of IE were included, 2113 from SE and 2082 from NCE; 2787 cases were included between 2000 and 2006 and 1408 between 2008 and 2012. Median (IQR) age was 63.7 (49-74) years and 69.4% were males. Native valve IE (NVE), prosthetic valve IE (PVE), and device-related IE were diagnosed in 68.3%, 23.9%, and 7.8% of cases, respectively; 52% underwent surgery and 19.3% died during hospitalization. NVE was more prevalent in NCE, whereas device-related IE was more frequent in SE. Higher age, acute presentation, hemodialysis, cancer, and diabetes mellitus all were more prevalent in the second period. NVE decreased and PVE and device-related IE both increased in the second period. Surgical treatment also increased from 48.7% to 58.4% (p < 0.01). In-hospital and 6-month mortality rates were comparable between regions and significantly decreased in the second period.Conclusions Despite an increased complexity of IE cases, prognosis improved in recent years with a significant decrease in 6-month mortality. Outcome did not differ according to the European region (SE versus NCE).